| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1007979822 |
| P356 | DOI | 10.1038/JID.2013.197 |
| P932 | PMC publication ID | 4267221 |
| P698 | PubMed publication ID | 23633021 |
| P5875 | ResearchGate publication ID | 236599709 |
| P50 | author | Thomas Giordano | Q37621567 |
| Leon Raskin | Q57688080 | ||
| Bhramar Mukherjee | Q65930870 | ||
| P2093 | author name string | Stephen B Gruber | |
| Dafydd G Thomas | |||
| Douglas R Fullen | |||
| Timothy M Johnson | |||
| Jaeil Ahn | |||
| Marcus L Frohm | |||
| Kelly B Cha | |||
| P2860 | cites work | Bioconductor: open software development for computational biology and bioinformatics | Q21194861 |
| HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity | Q24293207 | ||
| High mobility group A2 protein and its derivatives bind a specific region of the promoter of DNA repair gene ERCC1 and modulate its activity | Q24300124 | ||
| Cyclin A is required at two points in the human cell cycle | Q24329048 | ||
| Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7 | Q24649908 | ||
| Melanoma: new insights and new therapies | Q26853127 | ||
| RAS is regulated by the let-7 microRNA family | Q27860522 | ||
| Cancer statistics, 2012 | Q27860574 | ||
| Molecular dissection of the architectural transcription factor HMGA2 | Q28190810 | ||
| Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2 | Q28254493 | ||
| Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma | Q28276048 | ||
| A role for poly(ADP-ribose) polymerase in the transcriptional regulation of the melanoma growth stimulatory activity (CXCL1) gene expression | Q28345011 | ||
| Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome | Q29011337 | ||
| Molecular classification of cutaneous malignant melanoma by gene expression profiling | Q29619204 | ||
| The gene expression signatures of melanoma progression | Q30850724 | ||
| BRAF and NRAS mutations in melanoma and melanocytic nevi | Q33250357 | ||
| Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues | Q33272950 | ||
| MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth | Q33326420 | ||
| New strategies in melanoma: molecular testing in advanced disease | Q33943660 | ||
| HMG-I/Y, a new c-Myc target gene and potential oncogene | Q33964722 | ||
| Molecular biology of HMGA proteins: hubs of nuclear function | Q34095287 | ||
| HMGA2 overexpression in non-small cell lung cancer. | Q34625219 | ||
| Molecular regulation of melanocyte senescence | Q34722891 | ||
| A gene expression signature associated with survival in metastatic melanoma | Q35220047 | ||
| Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition. | Q36118227 | ||
| Oncogene-induced cell senescence--halting on the road to cancer | Q36587198 | ||
| The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis | Q36691376 | ||
| Melanoma biology and new targeted therapy | Q36742015 | ||
| DNA microarray analyses of melanoma gene expression: a decade in the mines | Q36970643 | ||
| Roles of HMGA proteins in cancer | Q37001370 | ||
| Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis | Q37288883 | ||
| Gene expression profiling of paraffin-embedded primary melanoma using the DASL assay identifies increased osteopontin expression as predictive of reduced relapse-free survival | Q37424329 | ||
| Melanoma prognostic model using tissue microarrays and genetic algorithms | Q37474252 | ||
| Review and cross-validation of gene expression signatures and melanoma prognosis. | Q37940188 | ||
| Integrating new therapies in the treatment of advanced melanoma | Q38022444 | ||
| Identification of genes with correlated patterns of variations in DNA copy number and gene expression level in gastric cancer. | Q38305699 | ||
| Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines | Q38329529 | ||
| High-resolution genomic profiling of adenomas and carcinomas of the salivary glands reveals amplification, rearrangement, and fusion of HMGA2. | Q38360384 | ||
| miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma | Q39884642 | ||
| C-MYC overexpression is required for continuous suppression of oncogene-induced senescence in melanoma cells | Q39954044 | ||
| Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma. | Q39954054 | ||
| HMGA2 gene is a promising target for ovarian cancer silencing therapy | Q39986056 | ||
| Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program | Q40251202 | ||
| Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays | Q40420929 | ||
| Microarray expression profiling in melanoma reveals a BRAF mutation signature. | Q40572664 | ||
| Cellular senescence in naevi and immortalisation in melanoma: a role for p16? | Q42016240 | ||
| Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization | Q44667553 | ||
| Novel genes associated with malignant melanoma but not benign melanocytic lesions | Q46226262 | ||
| Expression of mesenchyme-specific gene HMGA2 in squamous cell carcinomas of the oral cavity | Q47937358 | ||
| Ink4a/Arf regulation by let-7b and Hmga2: a genetic pathway governing stem cell aging. | Q51947006 | ||
| Reporting recommendations for tumor marker prognostic studies (REMARK). | Q53268902 | ||
| Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas | Q80408118 | ||
| High expression of DNA repair pathways is associated with metastasis in melanoma patients | Q81343404 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | transcriptome | Q252857 |
| biomarker | Q864574 | ||
| P304 | page(s) | 2585-2592 | |
| P577 | publication date | 2013-04-30 | |
| P1433 | published in | Journal of Investigative Dermatology | Q3186921 |
| P1476 | title | Transcriptome profiling identifies HMGA2 as a biomarker of melanoma progression and prognosis | |
| P478 | volume | 133 |
| Q50946912 | A Systems Biology Approach Identifies FUT8 as a Driver of Melanoma Metastasis. |
| Q38903238 | A melanoma subtype with intrinsic resistance to BRAF inhibition identified by receptor tyrosine kinases gene-driven classification. |
| Q55640224 | A meta-analysis of transcriptome datasets characterizes malignant transformation from melanocytes and nevi to melanoma. |
| Q38839711 | Amplified HMGA2 promotes cell growth by regulating Akt pathway in AML. |
| Q44937688 | BLIMP1 Induces Transient Metastatic Heterogeneity in Pancreatic Cancer |
| Q38603000 | CD271 determines migratory properties of melanoma cells. |
| Q36287435 | Characterization of long noncoding RNA and messenger RNA signatures in melanoma tumorigenesis and metastasis |
| Q33571911 | Childhood Body Size and the Risk of Malignant Melanoma in Adulthood |
| Q96952170 | Chondroitin polymerizing factor (CHPF) promotes development of malignant melanoma through regulation of CDK1 |
| Q37069223 | Established and Emerging Biomarkers in Cutaneous Malignant Melanoma |
| Q52731993 | Extracting Fitness Relationships and Oncogenic Patterns among Driver Genes in Cancer. |
| Q41816648 | HMGA2 is associated with epithelial-mesenchymal transition and can predict poor prognosis in nasopharyngeal carcinoma |
| Q47391313 | Harnessing BET Inhibitor Sensitivity Reveals AMIGO2 as a Melanoma Survival Gene |
| Q49288145 | High mobility group protein A2 overexpression indicates poor prognosis for cancer patients: a meta-analysis |
| Q38852100 | High-mobility group A2 overexpression is an unfavorable prognostic biomarker for nasopharyngeal carcinoma patients |
| Q58726181 | Hmga2 is dispensable for pancreatic cancer development, metastasis, and therapy resistance |
| Q33728215 | Hmga2 translocation induced in skin tumorigenesis |
| Q38303159 | IMP-3 promotes migration and invasion of melanoma cells by modulating the expression of HMGA2 and predicts poor prognosis in melanoma |
| Q101166253 | Identification of HMGA2 inhibitors by AlphaScreen-based ultra-high-throughput screening assays |
| Q45943042 | Identification of a gene signature for discriminating metastatic from primary melanoma using a molecular interaction network approach. |
| Q61814937 | Inhibition of Pannexin 1 Reduces the Tumorigenic Properties of Human Melanoma Cells |
| Q35900481 | Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma |
| Q38621140 | Integrative network and transcriptomics-based approach predicts genotype- specific drug combinations for melanoma |
| Q92756951 | Ion Channel Expression in Human Melanoma Samples: In Silico Identification and Experimental Validation of Molecular Targets |
| Q58721942 | Loss of GCNT2/I-branched glycans enhances melanoma growth and survival |
| Q47304492 | Lysyl oxidase-like 3 is required for melanoma cell survival by maintaining genomic stability |
| Q37702372 | Mapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq |
| Q39582357 | Microarray Analysis of Differentially-Expressed Genes Encoding CYP450 and Phase II Drug Metabolizing Enzymes in Psoriasis and Melanoma |
| Q40961149 | NLRP1 promotes tumor growth by enhancing inflammasome activation and suppressing apoptosis in metastatic melanoma. |
| Q52666846 | Network-Based Identification of Altered Stem Cell Pluripotency and Calcium Signaling Pathways in Metastatic Melanoma. |
| Q36513525 | Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway |
| Q36811094 | Stress from Nucleotide Depletion Activates the Transcriptional Regulator HEXIM1 to Suppress Melanoma. |
| Q64102412 | Synergy from gene expression and network mining (SynGeNet) method predicts synergistic drug combinations for diverse melanoma genomic subtypes |
| Q36009638 | The Response of microRNAs to Solar UVR in Skin-Resident Melanocytes Differs between Melanoma Patients and Healthy Persons |
| Q55490842 | The fucose salvage pathway inhibits invadopodia formation and extracellular matrix degradation in melanoma cells. |
| Q33631126 | Transcriptional dissection of melanoma identifies a high-risk subtype underlying TP53 family genes and epigenome deregulation |
| Q92709268 | Transposable elements drive widespread expression of oncogenes in human cancers |
Search more.